Abstract
Functional dyspepsia (FD) is characterised by epigastric pain and burning with a significant negative impact on quality-of-life and productivity. Prokinetic agents are widely used to treat FD in many Asian countries such as Vietnam. However, little is known with respect to cost-effectiveness and budget impact of these drugs as they are not approved for this indication in the Western world. The aim of this study is to investigate if the prokinetic itopride hydrochloride is a cost-effective option for the treatment of FD and the financial implication for broadening subsidised access in Vietnam.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
